Arif N. Ali

1.3k total citations · 1 hit paper
27 papers, 664 citations indexed

About

Arif N. Ali is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Arif N. Ali has authored 27 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Genetics. Recurrent topics in Arif N. Ali's work include Glioma Diagnosis and Treatment (7 papers), Brain Metastases and Treatment (6 papers) and Advanced Radiotherapy Techniques (6 papers). Arif N. Ali is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Brain Metastases and Treatment (6 papers) and Advanced Radiotherapy Techniques (6 papers). Arif N. Ali collaborates with scholars based in United States, Pakistan and Japan. Arif N. Ali's co-authors include Balney Rajitha, Kishore Kumar Jella, Sajani S. Lakka, Ganji Purnachandra Nagaraju, Zachary S. Buchwald, Neha Merchant, Roberto Díaz, Christopher D. Corso, Walter J. Curran and Hui‐Kuo G. Shu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Arif N. Ali

26 papers receiving 657 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

2022 104 citations Christina Tsien, Stephanie L. Pugh et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Arif N. Ali

Since Specialization

Citations

This map shows the geographic impact of Arif N. Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arif N. Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arif N. Ali more than expected).

Fields of papers citing papers by Arif N. Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arif N. Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arif N. Ali. The network helps show where Arif N. Ali may publish in the future.

Co-authorship network of co-authors of Arif N. Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Arif N. Ali. A scholar is included among the top collaborators of Arif N. Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arif N. Ali. Arif N. Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma breakdown → 2022 ·Journal of Clinical Oncology ·Christina Tsien, Stephanie L. Pugh, Adam P. Dicker, Jeffrey J. Raizer, M.M. Matuszak, Enrico C. Lallana, Jiayi Huang, Özer Algan, Nimisha Deb, Lorraine Portelance, John L. Villano, John Hamm, Kevin Oh, Arif N. Ali, Michelle M. Kim, Scott Lindhorst, Minesh P. Mehta	104
2	To determine the outcome of extracorporporeal shock waves lithotripsy for high density renal stone on non-contrast computed tomography. 2020 ·The Professional Medical Journal ·Arif N. Ali, (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	First in Human Measurements of Normal Tissue Oxygenation Via Electron Paramagnetic Resonance (EPR) Oximetry during and after Breast Radiation Therapy: Baseline Evaluations and Response to Hyperoxygenation 2019 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Xiuhong Yang, M.D. Martínez del Valle Torres, Junyi Lin, Wolfgang Schreiber, Harold M. Swartz, Benjamin B. Williams, Philip E. Schaner, Arif N. Ali	4
4	Machine-learning based classification of glioblastoma using delta-radiomic features derived from dynamic susceptibility contrast enhanced magnetic resonance images 2019 ·Quantitative Imaging in Medicine and Surgery ·Jiwoong Jeong, Liya Wang, Bing Ji, Yang Lei, Arif N. Ali, Tian Liu, Walter J. Curran, Hui Mao, Xiaofeng Yang	46
5	Clinical and Statistical Considerations when Assessing Oxygen Levels in Tumors: Illustrative Results from Clinical EPR Oximetry Studies 2019 ·Advances in experimental medicine and biology ·Ann Barry Flood, Philip E. Schaner, Peter Vaupel, Benjamin B. Williams, Bernard Gallez, (unknown), Arif N. Ali, (unknown), Victoria H. Lawson, Wolfgang Schreiber, Harold M. Swartz	11
6	A Prospective International Pilot Study Evaluating the Efficacy of a Self-Guided Contouring Teaching Module with Integrated Feedback for Transitioning from 2D to 3D Treatment Planning 2019 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Eduard Schreibmann, Jeffrey M. Switchenko, Mark W. McDonald, Jonathan J. Beitler, Walter J. Curran, Deborah Watkins Bruner, Pretesh Patel, (unknown), (unknown), Sibo Tian, Anees Dhabaan, Natia Esiashvili, Tian Liu, Arif N. Ali	1
7	ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA 2019 ·Neuro-Oncology ·Christina Tsien, Stephanie L. Pugh, Adam P. Dicker, Jeffrey J. Raizer, M.M. Matuszak, Enrico C. Lallana, Jiayi Huang, Özer Algan, Nicholas F. Taylor, Lorraine Portelance, John L. Villano, John Hamm, Kevin Oh, Arif N. Ali, Michelle Kim, Scott Lindhorst, Minesh P. Mehta	11
8	NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients 2018 ·Journal of Neuro-Oncology ·Arif N. Ali, Peixin Zhang, W.K. Alfred Yung, Yuhchyau Chen, Benjamin Movsas, Raul C. Urtasun, Christopher U. Jones, Kwang Nam Choi, Jeff M. Michalski, Andreas Fischbach, Arnold M. Markoe, Christopher J. Schultz, Marta Peñas-Prado, Madhur Garg, Alan C. Hartford, Harold E. Kim, Minhee Won, Walter J. Curran	25
9	Fractionated Radiotherapy Is Associated with Lower Rates of Treatment-Related Edema than Stereotactic Radiosurgery in Magnetic Resonance Imaging–Defined Meningiomas 2018 ·World Neurosurgery ·(unknown), (unknown), Jeffrey M. Switchenko, Bree R. Eaton, Ian Crocker, Arif N. Ali, Hui‐Kuo G. Shu	13
10	Matrix metalloproteinases: their functional role in lung cancer 2017 ·Carcinogenesis ·Neha Merchant, Ganji Purnachandra Nagaraju, Balney Rajitha, (unknown), Kishore Kumar Jella, Zachary S. Buchwald, Sajani S. Lakka, Arif N. Ali	152
11	Evaluating the Special Needs of The Military for Radiation Biodosimetry for Tactical Warfare Against Deployed Troops 2016 ·Health Physics ·Ann Barry Flood, Arif N. Ali, (unknown), Gaixin Du, (unknown), Steven G Swarts, Benjamin B. Williams, Eugene Demidenko, (unknown), Harold M. Swartz	16
12	Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme 2014 ·Radiation Oncology ·Arif N. Ali, (unknown), Claire Hardy, Hui‐Kuo G. Shu, Walter J. Curran, Ian Crocker	17
13	A model and nomogram to predict tumor site origin for squamous cell cancer confined to cervical lymph nodes 2014 ·Cancer ·Arif N. Ali, Jeffrey M. Switchenko, Sungjin Kim, Jeanne Kowalski, Mark W. El‐Deiry, Jonathan J. Beitler	9
14	Dosimetric and cost comparison of first fraction imaging versus fractional re-imaging on critical organ dose in vaginal cuff brachytherapy 2012 ·Practical Radiation Oncology ·Christopher D. Corso, (unknown), (unknown), Arif N. Ali, (unknown), Peter J. Rossi, Roberto Díaz	15
15	Comparing central nervous system (CNS) and extra‐CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program 2012 ·Cancer ·William A. Hall, Arif N. Ali, Norleena Gullett, Ian Crocker, Jerome C. Landry, Hui‐Kuo G. Shu, Roshan S. Prabhu, Walter J. Curran	12
16	Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy 2012 ·Practical Radiation Oncology ·Arif N. Ali, Peter J. Rossi, Karen D. Godette, Diego R. Martín, Stanley L. Liauw, Srinivasan Vijayakumar, (unknown), Ashesh B. Jani	17
17	Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignancies 2011 ·Medical dosimetry ·Arif N. Ali, Anees Dhabaan, (unknown), (unknown), Jerome C. Landry	21
18	Radiation-induced tumor neoantigens: imaging and therapeutic implications. 2011 ·PubMed ·Christopher D. Corso, Arif N. Ali, Roberto Díaz	47
19	A randomized biomechanical study of zone II human flexor tendon repairs analyzed in an in vitro model 1998 ·The Journal Of Hand Surgery ·(unknown), Arif N. Ali, (unknown), Daniel P. Mass	32
20	A randomized biomechanical study of zone II human flexor tendon repairs analyzed in a linear model 1998 ·The Journal Of Hand Surgery ·(unknown), Arif N. Ali, (unknown), Daniel P. Mass	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact